Clinical Trial Update: Evaluation of a Cohort of Congenital Deep Deafness Patients and/or With Auditory Neuropathy, Looking for DFNB9

View source ↗

Summary

This completed clinical trial evaluated a cohort of patients with congenital profound hearing loss and/or auditory neuropathy (DFNB9).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Auditory Neuropathy Spectrum Disorder
• Congenital Profound Hearing Loss

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Congenital Profound Hearing Loss | Status: COMPLETED